Zambia Chlorhexidine Application Trial (ZamCAT)
Impact of Chlorhexidine Cord Cleansing for Prevention of Neonatal Mortality in Zambia
Sponsor: Bill and Melinda Gates Foundation
Listed as NCT01241318, this PHASE2/PHASE3 trial focuses on Sepsis and remains completed. Sponsored by Bill and Melinda Gates Foundation, it has been updated 11 times since 2011, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE2_PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 6 earlier versions
-
Jun 2020 — Sep 2020 [monthly]
Completed PHASE2_PHASE3
-
Dec 2019 — Jun 2020 [monthly]
Completed PHASE2_PHASE3
-
Aug 2019 — Dec 2019 [monthly]
Completed PHASE2_PHASE3
-
Jun 2019 — Aug 2019 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jun 2019 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
Feb 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bill and Melinda Gates Foundation
- Boston University
- Ministry of Health, Zambia
- Zambia Center for Applied Health Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .